Inventor · disambiguated record
Cédrickx Godbout
Also filed as: GODBOUT CEDRICKX · GODBOUT CÉDRICKX
25 granted patents·18 pending applications·78 citations·filing 2000–2025
93Inventor score
Files withBOEHRINGER INGELHEIM INT33BEAULIEU PIERRE L3FADER LEE2LLINAS-BRUNET MONTSE2MERCK FROSST CANADA INC2
Top patents by PatentIndex Score
43 records- 0190US12043625B2Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jul 23, 2024·2 cites·55 claims
- 0289US11078182B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 3, 2021·4 cites·35 claims
- 0388US12065427B2Heterocyclic compounds capable of activating STINGBOEHRINGER INGELHEIM INT·Filed 2022·Granted Aug 20, 2024·1 cites·40 claims
- 0486US6200993B1Heterosubstituted pyridine derivatives as PDE4 inhibitorsMERCK FROSST CANADA INC·Filed 2000·Granted Mar 13, 2001·30 cites·19 claims
- 0585US6180650B1Heterosubstituted pyridine derivatives as PDE 4 inhibitorsMERCK FROSST CANADA INC·Filed 2000·Granted Jan 30, 2001·30 cites·21 claims
- 0683US11485727B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulatorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 1, 2022·1 cites·28 claims
- 0780US11319310B2Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted May 3, 2022·1 cites·16 claims
- 0880US11254688B2Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 22, 2022·1 cites·18 claims
- 0979US11136337B2Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Oct 5, 2021·1 cites·15 claims
- 1079US2025360141A1PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 1176US2024342186A1PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1275US10308667B2Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jun 4, 2019·1 cites·12 claims
- 1375US9994591B2Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 12, 2018·1 cites·38 claims
- 1475US9249158B2Cytomegalovirus inhibitor compoundsFADER LEE·Filed 2013·Granted Feb 2, 2016·3 cites·23 claims
- 1574US2023295112A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1673US12433897B2Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Oct 7, 2025·0 cites·65 claims
- 1771US8476257B2Viral polymerase inhibitorsBEAULIEU PIERRE L·Filed 2008·Granted Jul 2, 2013·1 cites·35 claims
- 1871US2023100516A1PyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1971US2024270718A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2070US2022048885A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2168US8541402B2Viral polymerase inhibitorsBEAULIEU PIERRE L·Filed 2012·Granted Sep 24, 2013·1 cites·15 claims
- 2267USRE49446EOxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Mar 7, 2023·0 cites·37 claims
- 2367US2023022770A1Novel pyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2465US2024174642A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2565US2024174641A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2664US11465982B2PyridazinesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 11, 2022·0 cites·28 claims
- 2764US2024208997A1Cyclic benzimidazole derivatives as cgas inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2864US2024327429A1[1,3]Thiazolo[4,5-d]-pyrimidon-7-ones as inhibitors of NOX4BOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2963US2024166629A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3062US12391667B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 19, 2025·0 cites·3 claims
- 3162US10864201B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Dec 15, 2020·0 cites·55 claims
- 3262US2024189315A1Cyclic Pyridine Derivatives as cGAS InhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3360US2021059992A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3454US8912182B2Viral polymerase inhibitorsBEAULIEU PIERRE L·Filed 2013·Granted Dec 16, 2014·0 cites·10 claims
- 3553US12358910B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jul 15, 2025·0 cites·14 claims
- 3651US12240828B2Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 3749US2010286131A1Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3845US11583532B2Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 21, 2023·0 cites·23 claims
- 3940US9926292B2Pyridinyl derivatives, pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 27, 2018·0 cites·21 claims
- 4040US9315499B2Cytomegalovirus inhibitor compoundsFADER LEE·Filed 2013·Granted Apr 19, 2016·0 cites·21 claims
- 4140US2011294778A1Hepatitis c inhibitor compoundsLLINAS-BRUNET MONTSE·Filed 2010·Application pending·0 cites
- 4240US2012077737A1Hepatitis c inhibitor compoundsLLINAS-BRUNET MONTSE·Filed 2010·Application pending·0 cites
- 4330US2011230465A1Viral polymerase inhibitorsBOEHRINGER INGLEHEIM INTERNAT GMBH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →